Life Science Nation Newsletter  |  August 13, 2015  |  Issue 124

  The LSN Story   |   Investor Platform   |   Company Platform   |   RESI Conference   |   Fundraising Accelerator
Life Science Investor Mandates (Aug. 6 - Aug. 12)
Seeking Early Stage Medical Devices
Seeking Investments in Medical Technology and Healthcare IT
Seeking Investment, In-Listening and M&A Opportunities in a Number of Indications
Seeking Wide Range of Medical Device Investments
In This Issue
Breakdown of Investors You Can Meet at RESI Boston

RESI Boston 2015 Corporate Venture Capital Announcement

LSN Summer Reading Series Chapter 12: "Anatomy of an Allocation Process"

LSN Videos
Video Recap of RESI@TMCx 2015

RESI@TMCx Investor Panel Videos

LSN in the News
Breakdown of Investors You Can Meet at RESI Boston
By Michael Quigley, Director of Research, LSN

The RESI Conference was built on helping fundraising entrepreneurs connect with a diverse set of early stage healthcare investors, and with 200 anticipated investors, our next RESI in Boston this September 16th is no exception. Figure 1 below breaks down the types of investors that are currently attending the conference...


RESI Boston 2015 Corporate Venture Capital Announcement
By Shaoyu Chang, MD, MPH,  Senior Research Analyst, LSN

Corporate venture capital (CVC) funds are playing an increasingly important role in the early stage ecosystem and now are participating in one out of every five VC deals in the US. Almost all major pharmaceutical companies have now established CVC funds; meanwhile giants from other industries are exploring the life sciences horizon through their CVC arms.

Moderated by Donnie Mcgrath, VP of Business Development, Bristol Myers Squibb, this panel will feature:
  • Mark Powers, CFO, Integrium
  • Martin Heidecker, Director and Investment Manager, Boehringer Ingelheim Venture Fund
  • Ann DeWitt, Senior Director, Sanofi-Genzyme BioVentures
  • Ed Hu, Chief Financial Officer & Chief Investment Officer, Wuxi Venture Partners
What technologies are on CVC managers' dreamlist? What are their key motivators and strategies? How should entrepreneurs start a dialogue with them? Experts from five prominent CVC funds will get together on the Corporate Venture Capital panel at RESI and speak their minds on these questions. You may have read our tips on partnering with CVC funds; RESI Boston will be a unique opportunity to meet them face-to-face...

LSN Summer Reading Series Chapter 12: "Anatomy of an Allocation Process"
By Lucy Parkinson, Senior Research Manager, LSN    

In recent weeks we've covered how to make a global target list of potential investors, and the basic techniques of phone canvassing and email outreach required to initiate dialogue. This week, LSN takes a look under the hood of the investment process. How do you turn that initial spark of interest into an allocation check?

This chapter explains how you can move the process forward through the pipeline and describes the people you'll have to work with in order to make the allocation happen-from the initial gatekeepers to the final decision-makers. We look at how to make a good first impression and how to run a productive meeting with an investor, and explore what will happen during the due diligence process. If you're preparing to meet with a potential investor in the near future, this chapter will be invaluable.